Products Liability News
CHARGES DRAG DOWN JAMPJ 4Q PROFIT BUT SALES REBOUND
January 25, 2012
A slew of charges for recalls, product liability, litigation and an acquisition dragged Johnson & Johnson's fourth-quarter profit down to barely a tenth of what the health care giant made a year ago, and some recalled products won't be back till year's end. But higher sales overseas boosted revenue enough to end an unprecedented two-year decline.
Full Story Below
